Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Reexamination Certificate
2007-09-04
2007-09-04
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
C424S192100, C435S069100, C435S069200, C435S183000
Reexamination Certificate
active
09807660
ABSTRACT:
The present invention provides soluble CD39 polypeptides and compositions, and methods for inhibiting platelet activation and recruitment in a mammal comprising administering a soluble CD39 polypeptide.
REFERENCES:
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5378601 (1995-01-01), Gepner-Puszkin
patent: 5506126 (1996-04-01), Seed et al.
patent: 5741771 (1998-04-01), Dawson et al.
patent: 5798241 (1998-08-01), Beaudoin et al.
patent: 6287837 (2001-09-01), Beaudoin et al.
patent: 6867177 (2005-03-01), Pinsky
patent: 0416673 (1991-03-01), None
patent: WO96/30532 (1996-10-01), None
patent: WO96/32471 (1996-10-01), None
patent: WO 00/23459 (2000-04-01), None
patent: WO 01/11949 (2001-02-01), None
Gayle et al, J Clin Invest 101(9): 1851-1859, May 1998.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz, et al., (ed.), Birkhauser, Boston, MA, pp. 492-495.
Skolnick et al., From genes to protein structure and function: novel applications of computational approaches in the genomic era, Jan. 2000, Trends in Biotech. 18(1): 34-39.
Mikayama et al, Proc. Natl. Acad. Sci, USA vol. 90: 10056-10060, Nov. 1993.
Grinthal et al, Biochemistry 41: 1947-56, 2002.
Attwood et al, The Babel of Bioinformatics, 2000, Science vol. 290 No. 5491: 471-473.
Chadwick and Frischauf,Genomics50:357, 1998.
Choudhri, et al.,J. Clin. Invest.102:1301, 1998.
Colman et al.,Blood68:565, 1986.
Connolly,J. Clin. Invest.97:209, 1996.
Connolly,Neurosurg.38(3):523, 1996.
* Cullen, DNA 7(9):645, 1998.
Gayle III, et al.,J. Clin. Invest.101(9):1851, 1998.
Handa and Guidotti,Biochem. Biophys. Res. Commun.218:916, 1996.
Kaczmarek et al.,J. Biol. Chem.271:33116, 1996.
Kansas and Tedder,J. Immunol.147:4094, 1991.
Maliszewski et al.,J. Immunol.153:3574, 1994.
Marcus and Safier,FASEB J7:516, 1993.
Marcus et al.,Clin. Res.40:226A (abstract), 1992.
Marcus et al.,J. Clin. Invest., 88:1690, 1991.
* Marcus et al.,J. Clin. Invest.99:1351, 1997.
Mulero et al.,J. Biol. Chem.274(29):20064, 1999.
Plesner, Int. Rev. Cytol. 158:141, 1995.
Rector et al.,Immunology55:481, 1985.
Ronaghi et al.,Science281:336, 1998.
Schoenborn, et al.,Cytogen Cell Gen.81(3-4):287, 1998.
Sevigny et al.,Biochem. Biophys. Acta1334:73, 1997.
Sevigny et al.,Biochem. J., 312:351, 1995.
Wang and Guidotti,J. Biol. Chem.271:9898, 1996.
Wang et al.,J. Biol. Chem.273:24814, 1998.
Gayle, III Richard B.
Maliszewski Charles R.
Marcus Aaron J.
Chan Christina
Cornell Research Foundation Inc.
Huynh Phuong
Immunex Corporation
Synnestvedt & Lechner LLP
LandOfFree
Methods of inhibiting platelet activation and recruitment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting platelet activation and recruitment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting platelet activation and recruitment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3730133